These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26025498)

  • 1. [Sleep and sleep disorders in the elderly: Part 3: Restless legs syndrome].
    Frohnhofen H; Schlitzer J
    Z Gerontol Geriatr; 2015 Jun; 48(4):379-87; quiz 388. PubMed ID: 26025498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
    Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R;
    Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targinact for restless legs syndrome.
    Drug Ther Bull; 2016 Apr; 54(4):42-5. PubMed ID: 27079737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
    Dostal M; Weber-Schoendorfer C; Sobesky J; Schaefer C
    Eur J Neurol; 2013 Sep; 20(9):1241-6. PubMed ID: 23083216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for restless legs syndrome.
    Ferini-Strambi L; Marelli S
    Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
    Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
    Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in restless legs syndrome (RLS).
    Högl B; Comella C
    Mov Disord; 2015 Sep; 30(11):1574-9. PubMed ID: 26371624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.
    Allen RP; Ondo WG; Ball E; Calloway MO; Manjunath R; Higbie RL; Lee MR; Nisbet PA
    Sleep Med; 2011 May; 12(5):431-9. PubMed ID: 21493132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET considerations for restless leg syndrome drug treatments.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on restless legs syndrome].
    Bartl M; Trenkwalder C; Muntean ML; Sixel-Döring FRK
    Nervenarzt; 2020 Oct; 91(10):955-966. PubMed ID: 32930812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The restless legs syndrome can be treated with dopamine agonists].
    Aramideh M; de Weerd AW
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2173-7. PubMed ID: 17061425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome.
    Frampton JE
    CNS Drugs; 2015 Jun; 29(6):511-8. PubMed ID: 26135898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1365-80. PubMed ID: 25149093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.
    Högl B; Paulus W; Clarenbach P; Trenkwalder C
    J Neurol; 2006 Aug; 253 Suppl 4():IV22-8. PubMed ID: 16944353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.